Sentence examples for clinical trials processes from inspiring English sources
Students in the PPTP will have unique opportunities to gain insight in to various aspects of the drug discovery process such as target validation, the drug approval process through the Food and Drug Administration, pre-clinical and clinical trials processes as well as entrepreneurial strategies used by start-up biotechnology companies.
In contrast others are concerned that early adoption of unproven stem cell interventions, outside ethical review and the clinical trials processes, places individuals at risk of personal harm.
The clinical trials process described above for FDA approval of new drugs has its counterpart in many other countries worldwide.
Research Pharmacy's involvement in the clinical trials process begins with protocol review by participating in the DF/HCC Scientific Review and Monitoring Process (PRMS).
In the past, he has investigated the impact of superstar researchers on the research productivity of their colleagues, and the outsourcing strategies of pharmaceutical firms, in particular the role played by contract research organizations in the clinical trials process.
This chapter discusses the patient perspective on the clinical trials process by communicating ideas and techniques that may encourage great scientific research institutions to take steps in making the clinical trial process more welcoming to more people, and improving the quality of care patients in trials receive.
By working together to harmonize procedures and requirements during the drug-approval process, needless duplication of efforts during the clinical trials process can be avoided in hopes of speeding the development of new treatments.
These roadblocks can be addressed by (i) characterizing trans-diagnostic, translational pathophysiological dimensions as potential treatment targets, (ii) efficiency, accountability and, transparency in approaches to the clinical trials process, and (iii) leveraging recent advances in genetics and in vitro phenotypes.
The costs of bringing new drugs from the laboratory, through the clinical trials process, and on to successful regulatory approval are skyrocketing, yet more investigational drugs are failing to meet expectations.
